First Roche, Then Bristol: Who’s Next?
This article was originally published in The Pink Sheet Daily
Executive Summary
This first article in a series takes an in-depth look at which pharma/biotech partnerships have the right chemistry to morph from collaboration to merger/acquisition.
You may also be interested in...
Adolor Seeks New Entereg Partner; Asks FDA To Weigh In On Chronic Use
GSK returns rights to alvimopan in outpatient settings; partnership continues for approved hospital use.
Adolor Seeks New Entereg Partner; Asks FDA To Weigh In On Chronic Use
GSK returns rights to alvimopan in outpatient settings; partnership continues for approved hospital use.
Sanofi Pasteur Nets Flu Vaccine Via Acambis Purchase
Early C. difficile program comes along with $550 million deal.